The share

Dicot Pharma's share was first listed in 2018 on Spotlight Stock Market and has been relisted on Nasdaq First North since November 2024. Today, we have over 9,100 shareholders, with a total share capital of SEK 12,451,458.894 distributed across 1,778,779,842 shares.

Nasdaq requires that all companies whose shares are admitted to trading on Nasdaq First North must engage a specially approved adviser who acts as a support for the companies and as an intermediary in contact with Nasdaq, a so-called Certified Adviser. Dicot Pharma engages FNCA Sweden AB for the role of Certified Adviser. Contact details: FNCA Sweden AB, Box 5216, SE-102 45 Stockholm, Sweden. Phone + 46 8 528 00 399. E-mail [email protected].